Shernan Holtan, MD
Associate Professor of Medicine, Division of Hematology, Oncology and Transplantation

Contact Info
Associate Professor of Medicine, Division of Hematology, Oncology and Transplantation
Medical Director, Clinical Trials Office Masonic Cancer Center Clinical Trials Office - Cell, Gene and Immunotherapy
Member, Masonic Cancer Center Executive Committee
Co-Chair, GVHD Cancer Center Translational Working Group
Director, Blood and Marrow Transplant Survivorship Clinic
Medical School, University of Nebraska, Omaha, NE
Residency, Mayo Clinic, Rochester, MN
Fellowship, Mayo Clinic, Rochester, MN
Summary
Dr. Holtan is an Associate Professor of Medicine in the Division of Hematology, Oncology, and Transplantation, where she serves as a hematologist focusing on allogeneic hematopoietic cell transplantation for malignant and non-malignant diseases, and long-term survivorship. Dr. Holtan brings a clinical/translational investigator focus on personalized immune monitoring, inflammation resolution, and the role of wound healing-associated growth factors in graft-versus-host disease. Her most recent research focuses on strength training and late effects related to transplantation. Dr. Holtan brings a strong track record of multidisciplinary research to the University of Minnesota.
Expertise
- Immunotherapy
- Allogeneic hematopoietic cell transplantation
- Graft versus host disease
- Long-term survivorship
- Strength Training
Awards & Recognition
Professional Associations
Research
Research Summary/Interests
- Personalized immune monitoring
- Inflammation resolution in GVHD
- Immunology of pregnancy
- Immunology of Cancer
- Strength Training
Clinical
Clinical Interests
BMT; cell therapy; GVHD; late effects